Brain serotonin deficiency affects female aggression.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 02 2019
04 02 2019
Historique:
received:
21
08
2018
accepted:
10
12
2018
entrez:
6
2
2019
pubmed:
6
2
2019
medline:
19
8
2020
Statut:
epublish
Résumé
The neurotransmitter serotonin plays a key role in the control of aggressive behaviour. While so far most studies have investigated variation in serotonin levels, a recently created tryptophan hydroxylase 2 (Tph2) knockout mouse model allows studying effects of complete brain serotonin deficiency. First studies revealed increased aggressiveness in homozygous Tph2 knockout mice in the context of a resident-intruder paradigm. Focussing on females, this study aimed to elucidate effects of serotonin deficiency on aggressive and non-aggressive social behaviours not in a test situation but a natural setting. For this purpose, female Tph2 wildtype (n = 40) and homozygous knockout mice (n = 40) were housed with a same-sex conspecific of either the same or the other genotype in large terraria. The main findings were: knockout females displayed untypically high levels of aggressive behaviour even after several days of co-housing. Notably, in response to aggressive knockout partners, they showed increased levels of defensive behaviours. While most studies on aggression in rodents have focussed on males, this study suggests a significant involvement of serotonin also in the control of female aggression. Future research will show, whether the observed behavioural effects are directly caused by the lack of serotonin or by potential compensatory mechanisms.
Identifiants
pubmed: 30718564
doi: 10.1038/s41598-018-37613-4
pii: 10.1038/s41598-018-37613-4
pmc: PMC6361930
doi:
Substances chimiques
Serotonin
333DO1RDJY
Tryptophan Hydroxylase
EC 1.14.16.4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1366Références
J Pharmacol Exp Ther. 1999 Mar;288(3):1125-33
pubmed: 10027850
Brain Res. 1999 Jul 24;835(2):104-12
pubmed: 10415365
Horm Behav. 2003 Feb;43(2):281-92
pubmed: 12694638
Physiol Behav. 2004 Oct 15;82(5):765-76
pubmed: 15451640
Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39
pubmed: 16310183
J Neural Transm (Vienna). 2008 Aug;115(8):1127-32
pubmed: 18665319
PLoS One. 2008;3(10):e3301
pubmed: 18923670
Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10332-7
pubmed: 19520831
Behav Brain Res. 2010 Feb 11;207(1):21-9
pubmed: 19782704
Behav Brain Res. 2010 Aug 25;211(2):220-8
pubmed: 20347882
Behav Brain Res. 2011 Jun 1;219(2):291-301
pubmed: 21262270
Physiol Behav. 2011 Jul 6;103(5):565-74
pubmed: 21549735
J Neurochem. 2012 Jun;121(6):974-84
pubmed: 22443164
Transl Psychiatry. 2012 May 29;2:e122
pubmed: 22832966
Neuron. 2012 Oct 4;76(1):175-91
pubmed: 23040814
PLoS One. 2012;7(11):e48975
pubmed: 23139830
Behav Brain Res. 2013 Apr 1;242:135-41
pubmed: 23291155
Psychol Bull. 2013 Sep;139(5):1148-72
pubmed: 23379963
Behav Brain Res. 2015 Jan 15;277:78-88
pubmed: 24928769
ACS Chem Neurosci. 2014 Oct 15;5(10):908-19
pubmed: 25089765
Psychopharmacology (Berl). 2015 Jul;232(14):2429-41
pubmed: 25716307
Front Behav Neurosci. 2016 May 26;10:97
pubmed: 27303275
Physiol Behav. 1986;36(4):653-8
pubmed: 2940609
Psychopharmacology (Berl). 1985;87(3):313-21
pubmed: 3936087
Biochem Pharmacol. 1968 Jul;17(7):1315-27
pubmed: 5690693
Pharmacol Biochem Behav. 1980 Feb;12(2):173-9
pubmed: 7189591
Science. 1995 Jun 23;268(5218):1763-6
pubmed: 7792602
Pharmacopsychiatry. 1995 Oct;28 Suppl 2:80-90
pubmed: 8614705
Psychiatry Res. 1979 Oct;1(2):131-9
pubmed: 95232